TMO · NYSE · STOCK
Thermo Fisher Scientific (TMO) Stock Analysis
$657.83
52W $435.27 – $694.33
59/100
$243.30B
35.3
0.88
Is TMO Bullish or Bearish?
Mixed.
Innellis AI committee rates Thermo Fisher Scientific (TMO) Watch with a composite score of 59/100
, based on 5 analysts with 80% agreement.
Last updated October 10, 2026.
What Would Change This View
- Upgrade to Buy
- Requires a committee score of 60.0 — +0.85 from today. Applies on the first day at or above the line; upgrades are never dampened.
- Downgrade to Reduce
- Requires the score to fall below 40.0 — -19.15 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.
Executive Summary
The primary driver is 5 consecutive earnings beats -- consistent execution. The main limiting factor is sector concentration is already high (hhi 2796.97). The committee is constructive but not yet at full conviction.
Bull & Bear Case
Bull Case
- 5 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- Price structure making higher highs and higher lows — Technical
- Trend and market structure agree -- coherent bullish picture — Technical
- Weekly trend (uptrend) confirms the daily trend -- multi-timeframe agreement — Technical
- News sentiment is positive (+0.27 across 44 articles, 14d) — News
Bear Case
- P/E of 34.9 is moderate-to-rich — Value
- Price-to-book of 4.1x prices in significant intangible value — Value
- MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or
forward-looking judgement. They summarise what the numbers say today.
Price History (6M)
AI Investment Committee
Committee Consensus
As of October 10, 2026
Overall Committee Score
59/100
Agreement
80%
Analysts
5
Conviction
High
Sector Rank
Top 37%
of 192 Healthcare peers
Value Analyst
bearish
35
/ 100 · Moderate confidence
Multiples don't clear a genuine value bar here, or cheapness looks justified by weak fundamentals
− P/E of 34.9 is moderate-to-rich
Growth Analyst
bullish
68
/ 100 · High confidence
Strong, accelerating growth with consistent execution
+ 5 consecutive earnings beats -- consistent execution
Technical Analyst
bullish
61
/ 100 · High confidence
Price action is constructive -- trend and momentum agree
+ Price structure making higher highs and higher lows
− MACD histogram negative -- bearish momentum
Macro Analyst
bullish
65
/ 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
News Analyst
bullish
66
/ 100 · Low confidence
News flow and recent filings/analyst actions are net positive
+ News sentiment is positive (+0.27 across 44 articles, 14d)
Portfolio Manager
bearish
30
/ 100 · Moderate confidence
The existing book itself argues for caution here, independent of how good this specific stock looks
− Sector concentration is already high (HHI 2796.97)
Investment Thesis Evolution
Committee score moved marginally from 59.1 to 59.1.
- New bearish signals: 1 appeared.
- Bullish support removed: 1 signal(s) disappeared.
- New bullish signals: 1 appeared.
- Bearish pressure eased: 1 signal(s) disappeared.
Analyst-level changes:
- News Analyst: +1 bullish signal(s).
- Value Analyst: +1 bearish signal(s).
Comparing 2026-10-09 to 2026-10-10 (1 day apart).
Technical Analysis
RSI (14)
49.2
Neutral
MACD Histogram
-3.722
Bearish Momentum
Trend Direction
Uptrend
Weekly: Uptrend
Market Structure
Hh Hl
Bollinger %B
0.47
Inside Bands
Price vs Moving Averages
EMA 9
$660.41
Below
EMA 21
$653.50
Above
EMA 50
$624.75
Above
EMA 200
$558.19
Above
Fundamental Analysis
Valuation
23
Growth
73
Profitability
63
Financial Health
74
Cash Flow
70
Valuation
P/E Ratio
35.3×
P/B Ratio
4.63×
PEG Ratio
4.75
Dividend Yield
0.28%
52W High
$694.33
52W Low
$435.27
Quality & Growth
ROE
1261.5%
ROA
610.6%
Gross Margin
4103.3%
Operating Margin
1797.1%
Revenue Growth YoY
—
Debt / Equity
0.81
AI Fundamental Assessment
P/E ratio of 35.3 (rich relative to a 15-40x range); Price-to-book of 4.6x; PEG ratio of 4.7 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 12.6%; Return on assets of 6.1%; Net margin of 15.1%; Gross margin of 41.0%; Current ratio of 1.55 (healthy short-term liquidity); Debt-to-equity of 0.81; Free cash flow per share is positive (19.73); Most recent quarter beat estimates by 4.5%; 5 consecutive earnings beats; EPS growth accelerating (-17.2% -> +10.8% QoQ); Average YoY EPS growth of 12.5%; Analyst estimates falling over recent quarters
Get the Full TMO Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →